Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mise en évidence de polysaccharides par le noir Soudan B après estérification.

Autor: Gabe, M., Pompidou, A., Schramm, B.

Publikováno v: Histochemie; 1972, Vol. 30 Issue 4, p297-306, 10p

UOS_IOTSH_2024: A Comprehensive network traffic dataset for sinkhole attacks in diverse RPL IoT networks.

Autor: Omar AARA; Department of Computer Engineering, College of Computing and Informatics, University of Sharjah, P.O.Box 27272, Sharjah, United Arab Emirates., Soudan B; Department of Computer Engineering, College of Computing and Informatics, University of Sharjah, P.O.Box 27272, Sharjah, United Arab Emirates., Altaweel A; Department of Computer Engineering, College of Computing and Informatics, University of Sharjah, P.O.Box 27272, Sharjah, United Arab Emirates.

Publikováno v: Data in brief [Data Brief] 2024 Jun 22; Vol. 55, pp. 110650. Date of Electronic Publication: 2024 Jun 22 (Print Publication: 2024).

B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure: de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. J Am Coll Cardiol 2004;43:1584–9

Publikováno v: In ACC Current Journal Review 2004 13(7):37-37

Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisis.

Autor: Collet A; Univ. Lille, Lille, F-59000, France, U1286-INFINITE-Institute for Translational Research in Inflammation.; INSERM, Lille, F-59000, France.; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France.; CHU Lille, Institut d'Immunologie, Pôle de Biologie Pathologie Génétique, Lille, F-59000, France., Sanges S; Univ. Lille, Lille, F-59000, France, U1286-INFINITE-Institute for Translational Research in Inflammation.; INSERM, Lille, F-59000, France.; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France.; CHU Lille, Institut d'Immunologie, Pôle de Biologie Pathologie Génétique, Lille, F-59000, France., Ghulam A; CHU Lille, Pôle de Biologie Pathologie Génétique, Service Hormonologie, Métabolisme, Nutrition, Oncologie, F59000 Lille, France., Genin M; Univ. Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, Lille, F-59000, France., Soudan B; CHU Lille, Pôle de Biologie Pathologie Génétique, Service Hormonologie, Métabolisme, Nutrition, Oncologie, F59000 Lille, France., Sobanski V; Univ. Lille, Lille, F-59000, France, U1286-INFINITE-Institute for Translational Research in Inflammation.; INSERM, Lille, F-59000, France.; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France., Hachulla E; Univ. Lille, Lille, F-59000, France, U1286-INFINITE-Institute for Translational Research in Inflammation.; INSERM, Lille, F-59000, France.; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France., Dubucquoi S; Univ. Lille, Lille, F-59000, France, U1286-INFINITE-Institute for Translational Research in Inflammation.; INSERM, Lille, F-59000, France.; CHU Lille, Institut d'Immunologie, Pôle de Biologie Pathologie Génétique, Lille, F-59000, France., Djobo B; CHU Lille, Pôle de Biologie Pathologie Génétique, Service Hormonologie, Métabolisme, Nutrition, Oncologie, F59000 Lille, France., Espiard S; CHU Lille, Department of Endocrinology, Diabetology, Metabolism and Nutrition, Lille, F-59000, France., Douillard C; CHU Lille, Department of Endocrinology, Diabetology, Metabolism and Nutrition, Lille, F-59000, France., Launay D; Univ. Lille, Lille, F-59000, France, U1286-INFINITE-Institute for Translational Research in Inflammation.; INSERM, Lille, F-59000, France.; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2023 Dec 23. Date of Electronic Publication: 2023 Dec 23.